RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)

Sponsor
London School of Hygiene and Tropical Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02160249
Collaborator
Addis Ababa University (Other)
166
1
2
20.2
8.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether community-based rehabilitation plus facility-based care is superior to facility-based care alone in reducing disability related to schizophrenia in rural Ethiopia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Community-based rehabilitation
  • Other: Facility based care
N/A

Detailed Description

This is a cluster randomised trial set in rural Ethiopia with kebeles (villages) as the unit of randomisation. 54 kebeles will be included. 27 will be randomly allocated to the intervention arm (Facility based care (FBC) + Community-based Rehabilitation (CBR)) and 27 randomly allocated to the control arm (FBC alone).

The aim is to determine whether CBR + FBC is superior to FBC alone in reducing disability related to schizophrenia, measured by the WHO Disability Assessment Schedule version 2.0 (WHODAS 2.0) at 6 and 12 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
166 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial
Study Start Date :
Sep 1, 2015
Actual Primary Completion Date :
Mar 26, 2017
Actual Study Completion Date :
May 8, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Community-based rehabilitation and facility based care

Community-based rehabilitation is delivered to participants and their caregivers at their home by a specialist CBR worker. It comprises psychoeducation, adherence support, rehabilitation (including self-care and social skills), family support groups and accessing existing community organisations. It also involves community awareness raising and education and mobilisation of community leaders. Facility based care (usual care) consists of anti-psychotic medication prescribed by a nurse or clinical officer in a health centre and basic psycho-education.

Behavioral: Community-based rehabilitation

Other: Facility based care

Active Comparator: Facility-based care

Facility based care (usual care) consists of anti-psychotic medication prescribed by a nurse or clinical officer in a health centre and basic psycho-education.

Other: Facility based care

Outcome Measures

Primary Outcome Measures

  1. Disability (36-item WHODAS (World Health Organisation Disability Assessment Schedule) 2.0) [12 months]

Secondary Outcome Measures

  1. Symptom severity (Brief Psychiatric Rating Scale- Expanded version (BPRS-E)) [6 and 12 months]

  2. Clinical Global Impression (CGI) [6 and 12 months]

  3. Relapse (Longitudinal Interval Follow up Evaluation: DSM-IV version (LIFE)) [6 and 12 months]

  4. Disability (36-item WHODAS 2.0) [6 months]

  5. Functioning (indigenous functioning scale) [6 and 12 months]

    Scale is currently under development. It is being designed and validated to measure functioning in people with severe mental illness in rural Ethiopia.

  6. Economic activity of patient (employment, income and household work) [6 and 12 months]

    Section includes current occupation (categories), employment status (categories), typical income (specific amount). Section also includes questions adapted from the WHO-DAS 12 and 36 relating to problems doing usual work task both generally and as a result of their mental illness (likert scale)

  7. Medication adherence (4 item Morisky Medication Adherence Scale) [6 and 12 months]

  8. Engagement with facility based care [6 and 12 months]

    Potential mediator

  9. Proportion with human rights problems (chaining or restraint)- self-reported [6 and 12 months]

    The outcome is the proportion chained, restrained or confined within last one month. Additional data on who perpetrated the chaining i.e. traditional healer/ family member will be collected.

  10. Nutritional status (BMI) [6 and 12 months]

  11. Serious adverse events [6 and 12 months]

  12. Economic activity of caregiver [6 and 12 months]

    Section includes current occupation (categories), employment status (categories), typical income (specific amount). Section also includes questions adapted from the WHO-DAS 12 and 36 relating to problems doing usual work tasks (likert scale).

  13. Caregiver burden (WHO Family Interview Schedule Impact section) [6 and 12 months]

  14. Caregiver depression (PHQ9 +1) [6 and 12 months]

  15. Patient medication adherence [6 and 12 months]

  16. Proportion with human rights problems (chaining or restraint)- Caregiver-reported [6 and 12 months]

    Caregiver to report presence of human rights problems relating to patient. The outcome is the proportion chained, restrained or confined within last one month. Additional data on who perpetrated the chaining i.e. traditional healer/ family member will be collected.

Other Outcome Measures

  1. Discrimination (DISC-12) [6 and 12 months]

    Potential mediator

  2. Health service use and costs [6 and 12 months]

    Potential mediator

  3. Depression (PHQ-9+1) [6 and 12 months]

    Potential confounder

  4. Access/ adherence to CBR and reasons for non-adherence [6 and 12 months]

    Potential mediator

  5. Social support (OSLO-3) [6 and 12 months]

    Potential mediator

  6. Stigma and discrimination (WHO Family Interview Schedule Stigma section) [6 and 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥18 years

  • Diagnosis of schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using (DSM-IV) criteria

  • Evidence of severe, enduring or disabling illness

  • Resident in kebele for >6 months and no immediate plans to leave the kebele

  • Has a primary caregiver who is willing to participate in the study

Exclusion Criteria:
  • No specific criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Psychiatry, College of Health Sciences, Addis Ababa University Addis Ababa Ethiopia

Sponsors and Collaborators

  • London School of Hygiene and Tropical Medicine
  • Addis Ababa University

Investigators

  • Principal Investigator: Mary De Silva, PhD MSc, London School of Hygiene and Tropical Medicine
  • Principal Investigator: Abebaw Fekadu, Addis Ababa University Department of Psychiatry

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
London School of Hygiene and Tropical Medicine
ClinicalTrials.gov Identifier:
NCT02160249
Other Study ID Numbers:
  • 7035
  • 100142/Z/12/Z
First Posted:
Jun 10, 2014
Last Update Posted:
May 10, 2017
Last Verified:
May 1, 2017

Study Results

No Results Posted as of May 10, 2017